General SHASTA trials show substantial triglyceride reductions with plozasiranBy Healthcare Propulsion StaffAugust 31, 20260 Plozasiran treatment resulted in substantial reductions in triglyceride levels in patients with severe hypertriglyceridemia after one year, according to…
